دورية أكاديمية

Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy

التفاصيل البيبلوغرافية
العنوان: Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy
المؤلفون: Cairoli, Roberto, Furneri, GianlucaAff2, IDs1291302309054x_cor2, Di Virgilio, Roberto, Veggia, Barbara, Ferrara, Felicetto
المصدر: BMC Health Services Research. 23(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:14726963
DOI:10.1186/s12913-023-09054-x